Showing results (1511-1520 of 1,565) with videos related to

Sort By:
Pageof 157
Lancet (London, England)|December 22, 2015
Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trialPatricia A Ganz, Reena S Cecchini, Thomas B Julian, et al.
Metabolism: Clinical and Experimental|May 21, 2026
Gut-liver metabolic and enterohormonal remodeling drives progression from metabolic dysfunction-associated steatotic liver disease to steatohepatitisJaclyn A Rivas, Alexandria C Murphy, Praveena Prasad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2023
Prospective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal AdenocarcinomaWilliam A Hall, Jiahe Li, Y Nancy You, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Dietary Microplastics Engage Gut Mechanosensory-Endocrine Signaling to Disrupt Bone HomeostasisAaron S Romero, Sumira Phatak, Sanchiti Patil, et al.
The Lancet. Oncology|August 15, 2015
Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trialHarry D Bear, Gong Tang, Priya Rastogi, et al.
American Journal of Respiratory Cell and Molecular Biology|November 9, 2017
LPS-induced Acute Lung Injury Involves NF-κB-mediated Downregulation of SOX18Christine M Gross, Manuela Kellner, Ting Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2012
Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancerEdward H Romond, Jong-Hyeon Jeong, Priya Rastogi, et al.
The New England Journal of Medicine|January 27, 2012
Bevacizumab added to neoadjuvant chemotherapy for breast cancerHarry D Bear, Gong Tang, Priya Rastogi, et al.
Lancet (London, England)|December 22, 2015
Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trialRichard G Margolese, Reena S Cecchini, Thomas B Julian, et al.
Neuro-Oncology|April 25, 2022
Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidityAndrea M Gross, Brittany Glassberg, Pamela L Wolters, et al.
Pageof 157